TCG CROSSOVER MANAGEMENT, LLC Viridian Therapeutics, Inc. Transaction History

TCG CROSSOVER MANAGEMENT, LLC portfolio value:

$23.87M
portfolio value

TCG CROSSOVER MANAGEMENT, LLC quarter portfolio value change:

+77.27%
quarter

Viridian Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -11.42% -150K shares 8.67M $20.51 1.16M
Q2 2022 share 0.00% 0 shares -9.09M $11.57 1.31M
Q1 2022 share 0.00% 0 shares -1.68M $18.49 1.31M
Q4 2021 share Increase 0.00% 1.31M shares 25.97M $20.3 1.31M